April 30, 2015

American physician survey finds that Americans are lacking the tools to fight chronic disease. 

April 21, 2015

A Frost & Sullivan report released Tuesday found the self-monitoring blood-glucose meter market is threatened by reimbursement pressure and technological advancements. 

March 24, 2015

A new report by Shoppers Drug Mart and Great-West Life demonstrates the importance of pharmacist interventions in diabetes management.

March 13, 2015

The CDC and AMA on Thursday launched the joint Prevent Diabetes STAT program. 

March 13, 2015

Wakefern's ShopRite has teamed up with Johnson & Johnson to create a Diabetes Center at its Flemington, N.J., location.

March 5, 2015

Walgreens and the Diabetes Research Institute Foundation will team up for the annual DRI Walk for Diabetes and Family Fun Day for the fifth consecutive year.

March 4, 2015

DexCom received Food and Drug Administration approval for its Dexcom G4 Platinum Continuous Glucose Monitor System with Share. The Share receiver uses a wireless connection via Bluetooth Low Energy between the patient’s receiver and an app on the patient’s smartphone to relay glucose information to apps on the mobile devices of up to five designated recipients, or “followers.”


February 26, 2015

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

February 23, 2015

Study finds that vitamin D depletion linked more closely to diabetes than obesity. 

February 18, 2015

Natural Product Solutions on Wednesday announced the launch of its new VirMax Blood Sugar Stabilization Formula.

February 10, 2015

The Wall Street Journal on Sunday reported that DexCom, a medical-device maker, is developing a diabetes glucose monitoring app to be compatible with the Apple Watch.

February 3, 2015

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets. 


February 3, 2015

Afrezza, an inhaled insulin powder, is now available by prescription in U.S. retail pharmacies, Sanofi and MannKind Corp. announced. The drug is approved by the Food and Drug Administration to control high blood sugar in adults who have type 1 and type 2 diabetes.


January 29, 2015

In December, DSN hosted its 14th annual Diabetes Roundtable, this time expanding the discussion to include other chronic conditions and community pharmacy’s role in driving prevention and improved health outcomes for patients.

January 27, 2015

Miraculins on Tuesday announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone, Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario.

January 22, 2015

Glucose Health recently launched a powder blend that can assist in the stabilization of healthy glucose levels, the company announced.

January 20, 2015

LifeScan on Tuesday introduced the new OneTouch Verio Blood Glucose Monitoring System that helps people with diabetes better understand their results without any extra effort.

January 12, 2015

The Pharmacy Quality Alliance on Monday announced the retirement of the performance measure, "Diabetes: Appropriate Treatment of Hypertension."

January 8, 2015

Data from a recent patient satisfaction study conducted by J.D. Power has found that Bayer blood glucose meters ranked highest in overall satisfaction among patients with diabetes.

January 6, 2015

People with type 1 diabetes who intensively control their blood glucose early in their disease are likely to live longer than those who do not.

January 5, 2015

Drug Store News recently interviewed Travis Shaw, VP sales and marketing for Owen Mumford about one of its newest products, Unifine Pentips Plus, a first-of-its-kind pen needle with a pen needle remover built into the device. The device is reported to show promise in improving patient compliance. 

December 29, 2014

Novo Nordisk last week announced that the Food and Drug Administration approved the company's new drug application for Saxenda, a once-daily glucagon-like peptide-1 receptor agonist used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults.

December 18, 2014

H-E-B donated $1 million to the University of Texas Rio Grande Valley to be used in the school's diabetes research program, according to a report from the Valley Morning Star published Thursday.

December 11, 2014

The Little Clinic and UC Health have announced that they are expanding on their relationship to include diabetes management, beginning in December, inside seven pilot program locations.